113 related articles for article (PubMed ID: 8610646)
1. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
Jacobs AJ; Blessing JA; Munoz A
Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial.
Weiss GR; Liu PY; O'Sullivan J; Alberts DS; Brown TD; Neefe JR; Hutchins LF
Gynecol Oncol; 1992 Jun; 45(3):303-6. PubMed ID: 1535329
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group Study.
Malfetano JH; Blessing JA; Jacobs AJ
Am J Clin Oncol; 1993 Feb; 16(1):47-9. PubMed ID: 8424404
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.
Weiss RB; Peterson BL; Allen SL; Browning SM; Duggan DB; Schiffer CA
Invest New Drugs; 1994; 12(1):41-3. PubMed ID: 7960604
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD; Hanjani P
Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
[TBL] [Abstract][Full Text] [Related]
7. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Blessing JA; Malfetano J
Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD
Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
Feun LG; Blessing JA; Barrett RJ; Hanjani P
Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
[TBL] [Abstract][Full Text] [Related]
12. Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study.
Kucuk O; Young ML; Habermann TM; Wolf BC; Jimeno J; Cassileth PA
Am J Clin Oncol; 2000 Jun; 23(3):273-7. PubMed ID: 10857892
[TBL] [Abstract][Full Text] [Related]
13. Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group.
Sondak VK; Kopecky KJ; Liu PY; Fletcher WS; Harvey WH; Laufman LR
Anticancer Drugs; 1994 Apr; 5(2):147-50. PubMed ID: 8049497
[TBL] [Abstract][Full Text] [Related]
14. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
Muss HB; Blessing JA; Eddy GL; McGehee R
Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
Lincoln S; Blessing JA; McGehee R; Lentz SS
Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.
Taylor SA; Goodman P; Crawford ED; Stuckey WJ; Stephens RL; Gaynor ER
Invest New Drugs; 1992 Apr; 10(1):55-6. PubMed ID: 1607254
[TBL] [Abstract][Full Text] [Related]
17. N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
Rajdev L; Yu ZF; Wadler S; Weller E; Kahn SB; Tormey D; Skeel R; Wiernik PH
Invest New Drugs; 2001; 19(3):233-7. PubMed ID: 11561680
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319).
Mittelman A; Chun HG; Puccio C; Coombe N; Lansen T; Ahmed T
Invest New Drugs; 1999; 17(2):179-82. PubMed ID: 10638489
[TBL] [Abstract][Full Text] [Related]
19. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical study of didemnin B. A National Cancer Institute of Canada Clinical Trials Group study.
Maroun JA; Stewart D; Verma S; Eisenhauer E
Invest New Drugs; 1998; 16(1):51-6. PubMed ID: 9740544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
